{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:54:32Z","timestamp":1782975272131,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00595-024-02920-z","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T06:57:28Z","timestamp":1724050648000},"page":"425-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Proposal of \u201cborderline resectable\u201d colorectal liver metastases based on analysis of risk factors for early surgical failure"],"prefix":"10.1007","volume":"55","author":[{"given":"Mizuki","family":"Ninomiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Takeishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Toshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Yoshiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Oki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"2920_CR1","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/bjs.10191","volume":"103","author":"J Hallet","year":"2016","unstructured":"Hallet J, Sa Cunha A, Adam R, Go\u00e9r\u00e9 D, Bachellier P, Azoulay D, et al. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases. Br J Surg. 2016;103:1366\u201376.","journal-title":"Br J Surg"},{"key":"2920_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1245\/s10434-014-3577-x","volume":"21","author":"T Beppu","year":"2014","unstructured":"Beppu T, Miyamoto Y, Sakamoto Y, Imai K, Nitta H, Hayashi H, et al. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival. Ann Surg Oncol [Internet]. 2014;21:405\u201313.","journal-title":"Ann Surg Oncol [Internet]"},{"key":"2920_CR3","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","volume":"27","author":"S Kopetz","year":"2009","unstructured":"Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677\u201383.","journal-title":"J Clin Oncol"},{"key":"2920_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/jhbp.1252","volume":"30","author":"K Sakamoto","year":"2023","unstructured":"Sakamoto K, Beppu T, Honda G, Kotake K, Yamamoto M, Takahashi K, et al. Comprehensive data of 4502 patients newly diagnosed with colorectal liver metastasis between 2015 and 2017, and prognostic data of 2427 patients newly diagnosed with colorectal liver metastasis in 2013 and 2014: Third report of a nationwide survey in Japa. J Hepatobiliary Pancreat Sci. 2023;30:570\u201390.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2920_CR5","first-page":"6655","volume":"34","author":"T Beppu","year":"2014","unstructured":"Beppu T, Emi Y, Tokunaga S, Oki E, Shirabe K, Ueno S, et al. Liver resectability of advanced liver-limited colorectal liver metastases following mFOLFOX6 with bevacizumab (KSCC0802 study). Anticancer Res. 2014;34:6655\u201362.","journal-title":"Anticancer Res"},{"key":"2920_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41416-019-0518-2","volume":"121","author":"E Oki","year":"2019","unstructured":"Oki E, Emi Y, Yamanaka T, Uetake H, Muro K, Takahashi T, et al. Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial). Br J Cancer [Internet]. 2019;121:222\u20139.","journal-title":"Br J Cancer [Internet]"},{"key":"2920_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.surg.2015.09.003","volume":"159","author":"M Oba","year":"2016","unstructured":"Oba M, Hasegawa K, Shindoh J, Yamashita S, Sakamoto Y, Makuuchi M, et al. Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases. Surgery. 2016;159:632\u201340.","journal-title":"Surgery"},{"key":"2920_CR8","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1007\/s00268-019-05142-4","volume":"43","author":"F Ratti","year":"2019","unstructured":"Ratti F, Fuks D, Cipriani F, Gayet B, Aldrighetti L. Timing of perioperative chemotherapy does not influence long-term outcome of patients undergoing combined laparoscopic colorectal and liver resection in selected upfront resectable synchronous liver metastases. World J Surg [Internet]. 2019;43:3110\u20139. https:\/\/doi.org\/10.1007\/s00268-019-05142-4.","journal-title":"World J Surg [Internet]"},{"key":"2920_CR9","first-page":"977","volume":"155","author":"M Bockhorn","year":"2014","unstructured":"Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surg (United States). 2014;155:977\u201388.","journal-title":"Surg (United States)"},{"key":"2920_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00534-011-0371-z","volume":"18","author":"S Takahashi","year":"2011","unstructured":"Takahashi S, Kinoshita T, Konishi M, Gotohda N, Kato Y, Kinoshita T, et al. Borderline resectable pancreatic cancer: Rationale for multidisciplinary treatment. J Hepatobiliary Pancreat Sci. 2011;18:567\u201374.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2920_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/ags3.12631","volume":"7","author":"T Noda","year":"2023","unstructured":"Noda T, Takahashi H, Tei M, Nishida N, Hata T, Takeda Y, et al. Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi-institutional retrospective study. Ann Gastroenterol Surg. 2023;7:479\u201390.","journal-title":"Ann Gastroenterol Surg"},{"key":"2920_CR12","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s10147-021-02024-5","volume":"26","author":"M Ninomiya","year":"2021","unstructured":"Ninomiya M, Emi Y, Motomura T, Tomino T, Iguchi T, Kayashima H, et al. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases. Int J Clin Oncol [Internet]. 2021;26:2255\u201364. https:\/\/doi.org\/10.1007\/s10147-021-02024-5.","journal-title":"Int J Clin Oncol [Internet]"},{"key":"2920_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00534-011-0460-z","volume":"19","author":"T Beppu","year":"2012","unstructured":"Beppu T, Sakamoto Y, Hasegawa K, Honda G, Tanaka K, Kotera Y, et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: Multicenter data collection as a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2012;19:72\u201384.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2920_CR14","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1245\/s10434-014-3504-1","volume":"21","author":"M Oba","year":"2014","unstructured":"Oba M, Hasegawa K, Matsuyama Y, Shindoh J, Mise Y, Aoki T, et al. Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: A potential surrogate endpoint for time to surgical failure. Ann Surg Oncol. 2014;21:1817\u201324.","journal-title":"Ann Surg Oncol"},{"key":"2920_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis [Internet]. 1987;40:373\u201383.","journal-title":"J Chronic Dis [Internet]"},{"key":"2920_CR16","first-page":"173","volume":"55","author":"T Yamaguchi","year":"2008","unstructured":"Yamaguchi T, Mori T, Takahashi K, Matsumoto H, Miyamoto H, Kato T. A new classification system for liver metastases from colorectal cancer in Japanese multicenter analysis. Hepatogastroenterology. 2008;55:173\u20138.","journal-title":"Hepatogastroenterology"},{"key":"2920_CR17","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1245\/s10434-015-4470-y","volume":"22","author":"E Shinto","year":"2015","unstructured":"Shinto E, Takahashi K, Yamaguchi T, Hashiguchi Y, Kotake K, Itabashi M, et al. Validation and modification of the Japanese classification system for liver metastases from colorectal cancer: a multi-institutional study. Ann Surg Oncol. 2015;22:3888\u201395.","journal-title":"Ann Surg Oncol"},{"key":"2920_CR18","first-page":"1","volume":"9","author":"D Zhu","year":"2014","unstructured":"Zhu D, Zhong Y, Wei Y, Ye L, Lin Q, Ren L, et al. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS ONE. 2014;9:1\u20136.","journal-title":"PLoS ONE"},{"key":"2920_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ctrv.2015.06.006","volume":"41","author":"R Adam","year":"2015","unstructured":"Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, et al. Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus. Cancer Treat Rev. 2015;41:729\u201341.","journal-title":"Cancer Treat Rev"},{"key":"2920_CR20","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1245\/s10434-017-5845-z","volume":"24","author":"Y Nishioka","year":"2017","unstructured":"Nishioka Y, Shindoh J, Yoshioka R, Gonoi W, Abe H, Okura N, et al. Clinical impact of preoperative chemotherapy on microscopic cancer spread surrounding colorectal liver metastases. Ann Surg Oncol. 2017;24:2326\u201333.","journal-title":"Ann Surg Oncol"},{"key":"2920_CR21","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s11605-019-04250-9","volume":"24","author":"S Kobayashi","year":"2020","unstructured":"Kobayashi S, Beppu T, Honda G, Yamamoto M, Takahashi K, Endo I, et al. Survival benefit of and indications for adjuvant chemotherapy for resected colorectal liver metastases\u2014a Japanese nationwide survey. J Gastrointest Surg. 2020;24:1244\u201360.","journal-title":"J Gastrointest Surg"},{"key":"2920_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","volume":"20","author":"C Springfeld","year":"2023","unstructured":"Springfeld C, Ferrone CR, Katz MHG, Philip PA, Hong TS, Hackert T, et al. Neoadjuvant therapy for pancreatic cancer. Nat Rev Clin Oncol [Internet]. 2023;20:318\u201337.","journal-title":"Nat Rev Clin Oncol [Internet]"},{"key":"2920_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","volume":"401","author":"K Nakachi","year":"2023","unstructured":"Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, et al. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2023;401:195\u2013203.","journal-title":"Lancet"},{"key":"2920_CR24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","volume":"371","author":"B Nordlinger","year":"2008","unstructured":"Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007\u201316.","journal-title":"Lancet"},{"key":"2920_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1470-2045(14)70105-6","volume":"15","author":"J Primrose","year":"2014","unstructured":"Primrose J, Falk S, Finch-Jones M, Valle J, O\u2019Reilly D, Siriwardena A, et al. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: The New EPOC randomised controlled trial. Lancet Oncol. 2014;15:601\u201311.","journal-title":"Lancet Oncol"},{"key":"2920_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/jso.23899","volume":"111","author":"GK Bonney","year":"2015","unstructured":"Bonney GK, Coldham C, Adam R, Kaiser G, Barroso E, Capussotti L, et al. Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi-center data analysis using LiverMetSurvey. J Surg Oncol. 2015;111:716\u201324.","journal-title":"J Surg Oncol"},{"key":"2920_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-019-1641-5","volume":"17","author":"H Ichida","year":"2019","unstructured":"Ichida H, Mise Y, Ito H, Ishizawa T, Inoue Y, Takahashi Y, et al. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. World J Surg Oncol. 2019;17:1\u20139.","journal-title":"World J Surg Oncol"},{"key":"2920_CR28","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","volume":"14","author":"B Nordlinger","year":"2013","unstructured":"Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14:1208\u201315.","journal-title":"Lancet Oncol"},{"key":"2920_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/jhbp.1256","volume":"30","author":"T Beppu","year":"2023","unstructured":"Beppu T, Yamamura K, Sakamoto K, Honda G, Kobayashi S, Endo I, et al. Validation study of the JSHBPS nomogram for patients with colorectal liver metastases who underwent hepatic resection in the recent era\u2014a nationwide survey in Japan. J Hepatobiliary Pancreat Sci. 2023;30:591\u2013601.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2920_CR30","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00595-018-1630-2","volume":"48","author":"K Yamashita","year":"2018","unstructured":"Yamashita K, Watanabe M, Mine S, Fukudome I, Okamura A, Yuda M, et al. The impact of the charlson comorbidity index on the prognosis of esophageal cancer patients who underwent esophagectomy with curative intent. Surg Today. 2018;48:632\u20139.","journal-title":"Surg Today"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-024-02920-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-024-02920-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-024-02920-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T07:46:04Z","timestamp":1740037564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-024-02920-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2920"],"URL":"https:\/\/doi.org\/10.1007\/s00595-024-02920-z","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest. Eiji Oki and Tomoharu Yoshizumi are members of the editorial board of Surgery Today.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Fukuoka City Hospital (Approval Number: 204). This study was conducted in accordance with the Declaration of Helsinki and in good clinical practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}